Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,491 across all filing types
Latest filing 2021-09-30 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Notification Letter to Registered Shareholders and Change Request Form
Report Publication Announcement Classification · 95% confidence The document is a letter dated 30 September 2021 from 3SBio Inc. informing shareholders about the publication of the 2021 Interim Report. It provides instructions on how shareholders can access the report electronically or request printed copies. It also includes a Change Request Form for shareholders to select their preferred language and means of receiving future corporate communications. The document does not contain the actual interim report or substantive financial data but is an announcement about the availability of the interim report and related corporate communications. Therefore, it is not the interim report itself but a publication announcement of the report.
2021-09-30 English
2021 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 Interim Report' and contains detailed sections including Company Overview, Corporate Information, Financial Highlights, Management Discussion and Analysis, Corporate Governance, Independent Review Report, and Interim Condensed Consolidated Financial Statements. It covers the six months ended 30 June 2021, providing comprehensive financial data and analysis, including revenue, profit, R&D costs, and EBITDA. The presence of interim condensed consolidated financial statements and detailed management discussion confirms this is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-09-30 English
Notification Letter and Request Form to Non-registered Shareholders - Notice of Publication of 2021 Interim Report
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated 29 September 2021 from Hongkong Chinese Limited informing non-registered shareholders about the publication of the 2021 Interim Report. It provides instructions on how to access the report online and how to request a printed copy. The document does not contain the actual interim financial statements or substantive financial data but rather serves as a notice of publication and a request form for shareholders to receive printed copies. According to the 'MENU VS MEAL' rule, such a document is an announcement regarding the availability of a report, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2021-09-28 English
Letter to Registered Shareholders - Notice of Publication of 2021 Interim Report
Report Publication Announcement Classification · 100% confidence The document is a notice of publication of the 2021 Interim Report of Hongkong Chinese Limited. It states that the Interim Report is now available on the company's and HKEX's websites and provides instructions on how shareholders can access it. The document itself does not contain the actual financial data or the report content but merely announces the availability of the report. The document length is short (2446 characters), consistent with an announcement rather than the full report. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA), not the Interim Report (IR) itself.
2021-09-28 English
2021 Interim Report
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements including condensed consolidated statements of profit or loss, comprehensive income, financial position, changes in equity, and cash flows. It also includes notes to the interim financial statements and a business review for the six months ended 30 June 2021. The presence of unaudited condensed consolidated interim financial statements for a six-month period indicates this is a comprehensive interim or quarterly report rather than a full annual report or a brief earnings release. The length of the document (15,000 characters) and the detailed financial data confirm it is a substantive financial report. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2021
2021-09-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchase of shares, including number of shares repurchased, prices, and confirmations that the repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases, not a full financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the stock exchange. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2021-09-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.